Women should have access to the medicines they need to live their best and fullest lives. Medicines360 is helping in a unique way.
OUR MISSIONThe Senator was a leading voice supporting the nonprofit pharmaceutical model in 2021, and will be in 2022 San Francisco, CA – Today, Medicines360 CEO Tina Raine-Bennett, MD, MPH, released the following statement. “The year 2021 will be remembered as a time the United States and the rest of the world faced incredible challenges. But […]
SAN FRANCISCO and NEW YORK, N.Y.: Medicines360, a mission-driven nonprofit women’s health pharmaceutical organization, and the Population Council, a global nonprofit research organization, have entered into a Memorandum of Understanding to develop a dual prevention pill (DPP) product to prevent both pregnancy and HIV in a single tablet – for global distribution. The organizations intend […]
Product Expands Access to High-Quality Contraception for Women in Africa SAN FRANCISCO and LONDON and NAIROBI– August 2, 2021 – Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg in Kenya. This is the third launch of Medicines360’s hormonal intrauterine device (IUD) in […]
We’re reinventing the pharma business model: we identify areas in women’s health where patients face limited choices, develop medicines that expand women’s options and make them available in ways that close gaps in access.
We believe women should have access to medicines, regardless of their diverse needs. As we choose products for development and study them in robust clinical trials, we tackle areas where many women struggle with limited medicine choices.
PRODUCTS & PIPELINE